Also listed on Astex Pharmaceuticals, Inc., an earlier holder on the record. The recorded assignments below show how it moved.
Term ends Jul 7, 2041 · High confidence
20-year base term ends Oct 7, 2040
Held by Taiho Pharmaceutical Co., Ltd.
Filed Apr 1, 2022 as application 17/766,074 · Granted Jan 7, 2025
Base term plus 273 days of patent term adjustment (USPTO delay)
Today
2020
2041
Clock starts
Oct 7, 2020
Oct 7, 2020
Term ends
Jul 7, 2041
Jul 7, 2041
Granted
Jan 7, 2025
Jan 7, 2025
base term
patent term adjustment
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
273
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
0 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
26
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 273 days past its 20-year base term on prosecution delay. 0 of 3 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Oct 7, 2020, when application PCT/US2020/054500, the earliest non-provisional in its chain, was filed (this one was filed Apr 1, 2022) | Oct 7, 2040 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +273 days, USPTO patent term adjustment record | Jul 7, 2041 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 0 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Jul 7, 2041 | High confidence |
This family
| US 6,613,753 | Term ended Mar 2021 | Mar 2021 |
| US 8,324,180 | In force Jul 2030 | Jul 2030 |
| US 8,329,665 | In force Jul 2030 | Jul 2030 |
| US 8,329,666 | In force Jul 2030 | Jul 2030 |
| US 8,609,631 | In force Apr 2030 | Apr 2030 |
| US 9,040,501 | In force Apr 2030 | Apr 2030 |
| Application PCT/US2014/062874 | PCT application no patent term | no patent term |
| US 9,834,576 | In force Oct 2034 | Oct 2034 |
8 of 26 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| May 2, 2022 Reel 59778, frame 135 | Zuend, Gemma; Scott, Ian; Davar, Nipun | Astex Pharmaceuticals, Inc. | Assignment of Assignor's Interest |
| May 2, 2022 Reel 59778, frame 313 | Astex Pharmaceuticals, Inc. | Otsuka Pharmaceutical Co., Ltd. | Assignment of Assignor's Interest |
| May 27, 2022 Reel 60036, frame 442 | Annaka, Kimiyoshi; Miyake, Masahiro; Matsui, Motoshi | Otsuka Pharmaceutical Co., Ltd. | Assignment of Assignor's Interest |
| Jan 16, 2025 Reel 69899, frame 399 | Otsuka Pharmaceutical Co., Ltd. | Taiho Pharmaceutical Co., Ltd. | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
Jul 2041
Term ends Jul 7, 2041. Maintenance fees still fall due before then
Note
The 273 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
0
later US patents cite this one
Fewer than half of the utility patents granted in 2025 in our data have been cited yet, so we show the count and do not rank on it.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.